Market Access Strategy

market access strategyThe pharmaceutical market access landscape has become more complex. In today’s market, bringing a product through a clinical development program is not enough to guarantee success. Market access strategies are rapidly evolving to meet the challenges of an increasingly demanding environment for drug pricing, reimbursement and uptake. Price and access pressures to demonstrate comparative product value and cost-effectiveness is building relentlessly and is forcing manufacturers to up their game with the skills critical for success:

  • True insight and prognostication of market trends

  • Defining and delivering a compelling value story to medical and business minded payer teams

  • Expert contract negotiation with distributors and payers

  • Training and guiding field teams to understand opportunities and execute key account management skills

Through our network, Herspiegel Consulting has the proprietary intellectual assets and deep relationships with key opinion leaders in managed markets to deliver on these critical success factors. Our work is grounded in a solid understanding of all managed market channels throughout a product lifecycle. The solutions we recommend are integrated seamlessly into the brand and payer marketing strategies and transcend across payers, healthcare providers, and patients to optimize your product’s value.

Recent Projects Include:

  • Payer value proposition

  • 340B strategy

  • Pricing and contracting strategy

  • Distribution strategy for hospital and home health care markets

  • Account executive training platform, account tools and live training

  • HUB service/patient support design and implementation

Latest Blogs

Innovative Drug Pricing via “Netflix Model”

March 1, 2019
Louisiana seeks “Netflix model” for hepatitis C drug pricing In January 2019, the Louisiana ...
Read more

Planning for 505(b)2 Commercial Success

October 17, 2018
Unlike generics and biosimilars, 505(b)2 regulatory products likely involve a unique claim. While 505(b)...
Read more

Fed-Up Hospitals are Starting Their Own Drug Company to Lower Generic Drug Prices

February 12, 2018
The impact of drug shortages is not new within the healthcare system, particularly at the hospital level...
Read more

FDA Continued Rejections of Citizen Petitions Highlights Key Lifecycle Challenges for Biologic Manufacturers

January 24, 2018
Citizen petitions have historically been a tool in the brand manufacturer’s toolkit of “product life...
Read more